Novo Nordisk shares fall 5.4% after latest trial results for its next-generation weight loss drug

Thread starter International: Top News And Analysis
Start date Mar 10, 2025

International: Top News And Analysis

Guest

Mar 10, 2025

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk shares fall 5.4% after latest trial results for its next-generation weight loss drug

Prefix: N/A

Forum: World News

Start date: Mar 10, 2025

Last reply date: Mar 10, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Mar 10, 2025

Replies: 0

Views: 79

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search